One group found that PAK4 can relieve the senescence-like growth arrest of BC cells by inhibiting the RELB subunit of the NF-κB (RELB) – CCAAT/enhancer-binding protein beta (CEBPB) pathway [63]. Here, PAK4 is linked to breast cancer.